[Comparison between the immunological and morphological classifications of malignant immunocytomas]

Area of Science:

• Hematology
• Oncology
• Immunology

Background:

• Malignant immunocytomas require precise classification for effective treatment.
• Traditional morphological classifications (e.g., Rappaport) have limitations in guiding clinical decisions.
• Immunological classifications (e.g., Lukes-Collins, Lennert) emerged to provide more detailed cellular information.

Purpose of the Study:

• To compare the clinical utility of immunological versus morphological classifications for malignant immunocytomas.
• To evaluate which classification system offers better insights for diagnosis and therapy.
• To assess the practical application of different classification systems in a clinical setting.

Main Methods:

• A retrospective analysis of 92 diagnosed and treated cases of malignant immunocytomas.
• Comparison of diagnostic and therapeutic data derived from immunological (Lukes-Collins, Lennert) and morphological (Rappaport) classification systems.
• Clinical data review from the Ward of Onco-Hematology, Zvezdara KHC, Belgrade.

Main Results:

• Immunological classifications provided more relevant clinical data for diagnosis compared to morphological methods.
• Therapeutic strategies were better informed by the insights gained from immunological classifications.
• The study demonstrated a clear advantage of immunological systems in guiding patient management.

Conclusions:

• Immunological classifications (Lukes-Collins, Lennert) are clinically superior to the morphological Rappaport classification for malignant immunocytomas.
• These immunological systems offer enhanced data for diagnosis and treatment planning.
• The findings support the adoption of immunological classification in routine clinical practice for immunocytoma management.